Custom Antibody Service

OverviewPlatform

Overview

Biologics have transformed the landscape of modern medicine, offering targeted solutions for cancer, chronic inflammatory diseases, autoimmune disorders, and beyond. Antibodies, in particular, continue to serve as foundational assets in therapeutic development, translational research, diagnostics, and mechanistic studies.

However, advancing an antibody program from concept to development-ready material requires more than simply binding affinity. It demands strategic antigen design, robust screening, rigorous characterization, and scalable production pathways. Creative Biogene's antibody platform is built for scientific rigor, flexible engagement, and downstream compatibility with regulatory and manufacturing pathways—bridging the gap between research and translational success.

What Sets Our Antibody Platform Apart

Creative Biogene approaches antibody development as a science-driven, application-aware process, not a transactional reagent delivery. Our workflows are designed to balance early-discovery flexibility with the downstream robustness needed for regulatory translation.

Strategic Antigen Design

Antibody performance is determined at the earliest stage—how the antigen is chosen and presented.

Rational epitope design focused on structural accessibility
PTM-sensitive and conformation-specific constructs
Custom peptides, proteins, or domain fragments to fit project needs

Strategic antigen design increases the likelihood of high-specificity, high-function binders suitable for diverse assay formats.

Integrated Antibody Discovery and Screening

Rather than delivering minimal characterization, Creative Biogene emphasizes application-driven screening. Candidate antibodies are evaluated not just for binding, but for application performance across biological contexts.

Typical evaluation includes:

ELISA and binding kinetics (SPR / BLI)
Flow cytometry (FACS) and immunofluorescence
Western blot, immunohistochemistry (IHC / ICC)
Functional assays (CDC / ADCC / cell killing where relevant)

This ensures antibodies are fit-for-purpose, not just binders.

Scalable, Consistent Production Pathways

As programs mature, supply continuity and batch consistency become critical. Creative Biogene supports scalable production strategies matched to client goals.

Production pathways include:

Hybridoma preservation and culture
Transient and stable recombinant expression in mammalian systems
Lot-to-lot consistency tracking
Process selectivity to support downstream analytical comparability

Our upstream and downstream development is guided by best-practice process characterization to ensure reproducibility and data traceability.

Analytical and Quality Characterization

A robust antibody program requires clear molecular understanding. Our analytical platform supports core characterization aligned with industry expectations (ICH Q6B), including:

Capability	Purpose
Mass confirmation (LC-MS)	Accurate identity and molecular mass
Peptide mapping	Sequence coverage and PTM profiling
Aggregation & purity profiling	SEC / CE-SDS
Higher-order structure	CD / FT-IR / DSC
Binding kinetics	SPR / BLI for functional confirmation

This analytical foundation can support research, translational decisions, and upstream readiness for regulated environments.

Microbiological Safety and Stability Testing

We provide safety and stability evaluation tailored to antibodies destined for in vivo or translational studies.

Endotoxin testing with high sensitivity
Bioburden and sterility screening
Forced degradation and real-time stability studies
Formulation screening for performance and storage

These studies inform handling recommendations and strengthen program characterization.

GMP Antibody Development & IND Support

Creative Biogene also provides GMP-aligned production pathways for projects advancing toward preclinical and IND stages.

Controlled manufacturing environments and traceability
Defined standard operating procedures and quality documentation
Batch records and certificates suitable for regulatory integration
Indication-specific release strategies

We tailor GMP engagement based on program strategy to avoid unnecessary cost or complexity while providing a clear path toward regulated use.

Explore Our Antibody Service Tracks

Creative Biogene offers tailored antibody development services designed to support diverse formats and scientific needs.

Single Domain Antibody Development and Production

Compact, high–tissue-penetration antibodies for challenging targets

Monoclonal Antibody Development and Production Service

Classic mAb discovery, screening, and development for research and translational use

Bispecific Antibody Development and Production Services

Custom dual-target formats and advanced engineering strategies

Why Partner with Creative Biogene

Creative Biogene's antibody platform is built on scientific depth, analytical confidence, and translational insight, offering:

A discovery-centric yet translationally aware workflow
Multi-format support with engineering flexibility
Deep analytical characterization capabilities
Scalable development pathways with optional GMP translation
Responsive project management and client communication

Whether you are validating a novel target, generating assay-ready tools, or preparing for translational milestones, Creative Biogene delivers tailored antibody solutions designed for performance, consistency, and future growth.

Advance Your Antibody Program with Confidence

Contact Creative Biogene to discuss your project objectives, antibody format requirements, and development strategy. We offer flexible engagement models, including project-based fee-for-service support, dedicated resource partnerships for multi-phase programs, and IND-focused development with regulatory-aligned documentation. Our teams work closely with partners to define scope, manage timelines, and align deliverables, ensuring a smooth transition from antibody discovery to translational success and clinical readiness.

Quick Inquiry